HONG KONG, March 24, 2022 /PRNewswire/ -- China Life
Insurance Company Limited (SSE: 601628, SEHK: 2628, NYSE: LFC)
announces the audited consolidated results of the Company (China
Life Insurance Company Limited and its subsidiaries) for the year
ended 31 December 2021 (the
"Reporting Period") prepared under the International Financial
Reporting Standards today.
Highlights
- As at the end of
the Reporting Period, the Company's total assets reached
RMB4,891,085 million, an increase of 15.0% from the end of 2020.
The Company's embedded value reached RMB1,203,008 million, an
increase of 12.2%, maintaining the leading position in the
industry.
- During the
Reporting Period, the Company's total revenues were RMB824,930
million, an increase of 2.5% year on year; the Company's gross
written premiums were RMB618,327 million, maintaining industry
leadership position; the value of one year's sales of the Company
was RMB44,780 million.
- As at the end of
the Reporting Period, the Company's investment assets reached
RMB4,716,401 million, an increase of 15.2% from the end of 2020.
During the Reporting Period, the gross investment yield was 4.98%,
the net investment yield was 4.38%. The comprehensive investment
yield taking into account the current net fair value changes of
available-for-sale securities recognized in other comprehensive
income was 4.87%.
- During the
Reporting Period, net profit attributable to equity holders of the
Company was RMB50,921 million.
- The board of
directors of the Company recommended the payment of a final
dividend of RMB0.65 per share (inclusive of tax). The foregoing
profit distribution plan is subject to the approval by the 2021
Annual General Meeting to be held on 29 June 2022
(Wednesday).
|
Review of Business Operations in 2021
In 2021, the worldwide COVID-19 pandemic continued to evolve,
and the domestic economy was facing triple pressures of
shrinking demands, supply disruption, and weakened expectations of
growth amid a complicated and challenging international
environment. Under the unprecedented pressures, such as the
decelerated release of insurance demands and decline of sales
force, the growth of life insurance industry further slowed down in
terms of premiums. In addition, the insurance industry regulator
continued to promote the return to its original role by the
insurance sector, further improved system building, and bolstered
regulations in the areas of insurance product
management, sales channel development, market behaviors,
operations and services as well as corporate governance, with an
aim at the high-quality development of the industry.
During the Reporting Period, the Company adhered to the
strategic core of "Three Major Transformations, Dual Centers and
Dual Focuses, Asset-liability Interaction," and upheld the
operational guideline of "prioritizing business value,
strengthening sales force, achieving stable growth, upgrading
technology, optimizing customer services and guarding against
risks." By concentrating efforts and overcoming difficulties with
strong resilience, the Company steadfastly promoted its
high-quality development while proceeding with routine pandemic
prevention and control, and achieved stable and sound business
operations as a whole, with its market leading position further
solidified. The quality and efficiency of its operations and
services were significantly improved, digital transformation was
sped up, and its comprehensive strengths were greatly enhanced.
During the Reporting Period, while the life insurance
industry was under pressure and the growth of premiums continued to
slow down, the Company prioritized business value and pushed
forward transformation and upgrade, and maintained the industry
leadership position in both business scale and value. In 2021,
the Company's gross written premiums amounted to RMB618,327 million, an increase of 1.0% year on
year, and renewal premiums reached RMB442,463 million, an increase of 5.8% year on
year. As at the end of the Reporting Period, the embedded value of
the Company reached RMB1,203,008
million, an increase of 12.2% from the end of 2020. Due to
the impact of the pandemic and the slowdown in the release of
demands for insurance consumption, premiums from new policies were
RMB175,864 million, a decrease of
9.3% year on year. The first-year regular premiums were
RMB98,410 million, a decrease of
14.7% year on year; in particular, first-year regular premiums with
a payment duration of ten years or longer were RMB41,682 million, a decrease of 26.1% year on
year. In 2021, the value of one year's sales of the Company was
RMB44,780 million, a decrease of
23.3% year on year. The number of long-term in-force policies was
323 million, an increase of 1.9% from the end of 2020. The
surrender rate was 1.20%, an increase of 0.11 percentage point year
on year.
During the Reporting Period, in the face of a complex and
changing market situation, the Company always maintained its
strategic consistency, reinforced asset-liability management,
firmly implemented its medium- to long-term strategic plan of asset
allocation, and continuously optimized its allocation management by
centering on the investment value creation chain. In 2021, the
Company flexibly made tactical allocations in response to the
market change, taking into account short-term income stability,
prevention of key risks, and long-term opportunities. The gross
investment income amounted to RMB214,057
million, an increase of 7.8% year on year, and the gross
investment yield was 4.98%.
In 2021, the Company maintained stable and sound business
operations and achieved satisfactory results in investment. It
updated the discount rate assumptions for reserves of traditional
insurance contracts based on market information as at the date of
the statement of financial position. Taking the above factors into
account, net profit attributable to equity holders of the Company
was RMB50,921 million, an increase of
1.3% year on year.
Insurance Business
During the Reporting Period, gross written premiums from the
life insurance business of the Company amounted to RMB481,311 million, rising by 0.1% year on year,
gross written premiums from the health insurance business reached
RMB120,609 million, rising by 4.8%
year on year, and gross written premiums from accident insurance
business were RMB16,407 million, a
year-on-year decrease of 1.1%.
In 2021, facing persistent impacts of the COVID-19 pandemic and
a challenging market environment, the industry faced unprecedented
pressure for transformation. The Company continued to deepen the
customer-centric sales deployment of "Yi Ti Duo Yuan", focusing on
business restructuring and making breakthroughs, and stressing
precise allocation of resources on the basis of standardized
management. The individual agent business sector consistently
prioritized business value and further promoted operation
differentiation between sales teams. The diversified business
sector achieved progress while maintaining stability and
coordinated effectively with the individual agent business sector
by concentrating on specialized operations, quality and efficiency
enhancement, and transformation and innovation. As at the end of
the Reporting Period, the number of total sales force of the
Company was approximately 890,000.
Individual Agent Business Sector
The individual agent business sector pursued high-quality
development, consistently deepened business restructuring, and
achieved steady business development. During the Reporting Period,
gross written premiums from the sector were RMB509,489 million, a decrease of 0.3% year on
year. Renewal premiums amounted to RMB407,973 million, an increase of 4.3% year on
year. First-year regular premiums were RMB82,254 million, a decrease of 17.4% year on
year, of which first-year regular premiums with a payment duration
of ten years or longer were RMB41,580
million, a decrease of 26.0% year on year. In 2021, the
value of one year's sales of the sector was RMB42,945 million, a decrease of 25.5% year on
year, and new business margin of one year's sales by annual premium
equivalent was 42.2%, a decrease of 5.9 percentage points year on
year.
Affected by sporadic outbreaks of the pandemic and the
challenging market environment, the whole industry had difficulties
in agent recruitment and retention, and the size of sales force
consequently declined to a certain extent. The Company adhered to
the sales force development strategy of improving quality with
stabilised quantity, and made great efforts in enhancing its
quality. As at the end of the Reporting Period, the number of
agents of the sector was 820,000, including 519,000 agents from the
general sales team and 301,000 agents from the upsales team. The
monthly average productive agents decreased compared with the
previous year, however, the number of high-performance agents was
stable, and the foundation of sales force remained solid. Although
the sector's development was under pressure, the Company adhered to
the strategy of "productive agents-driven business" and made solid
stride in business restructuring. The 4.0 version of the regular
agent management system was fully promoted and implemented, and
transformation of sales team was pushed forward aiming at becoming
more specialized and professional.
Diversified Business Sector
Pushing forward "Dingxin Project" deployment in great depth, the
diversified business sector concentrated on professional operation
as well as quality and efficiency enhancement, and actively
developed the bancassurance, group insurance, and health insurance
businesses.
Bancassurance Channel With equal emphasis on
business scale and value, the bancassurance channel consistently
pushed forward sound and healthy development. During the Reporting
Period, gross written premiums from the channel amounted to
RMB49,326 million, an increase of
19.6% year on year. First-year regular premiums were RMB16,110 million, an increase of 2.3% year on
year; in particular, first-year regular premiums with a payment
duration of five years or longer were RMB6,743 million, an increase of 35.3% year on
year. Renewal premiums amounted to RMB32,792
million (a year-on-year increase of 30.6%), accounting for
66.48% of gross written premiums from the channel (a year-on-year
increase of 5.59 percentage points). The bancassurance channel
constantly enhanced the professional service support capability of
the sales team, and the quality of which was steadily improved. As
at the end of the Reporting Period, the number of the channel's
account managers was 25,000, the quarterly average active managers
remained stable, and the productivity per manager increased
continuously.
Group Insurance Channel The group insurance
channel insisted on the coordination of business scale and
profitability and achieved stable development in all business
lines. During the Reporting Period, gross written premiums from the
channel were RMB29,162 million, an
increase of 1.0% year on year. Short-term insurance premiums from
the channel were RMB25,694 million,
an increase of 2.9% year on year. As at the end of the Reporting
Period, the number of group insurance sales representatives was
45,000, among which the high-performance personnel increased by
13.0% from the end of 2020.
Other Channels In 2021, gross written
premiums from other channels were RMB30,350
million, a decrease of 2.4% year on year. The Company
proactively participated in a variety of government-sponsored
health insurance businesses. As at the end of the Reporting Period,
the Company carried out over 200 supplementary major medical
expenses insurance programs, covering 350 million people. It also
undertook over 400 health care entrusted programs, providing
services to more than 100 million people; 61 long-term care
insurance programs in 17 provinces and cities, covering 23 million
people; and 170 supplementary medical insurance programs in 22
provinces and cities, covering 91 million people. The Company also
participated in the construction of a multi-level social security
system and implemented 54 city-customized commercial medical
insurance projects in 15 provinces and cities, covering more than
10 million people.
In addition, the Company greatly developed the online insurance
business and provided customers with high-quality service
experience through online-to-offline sales and online direct sales.
In full compliance with the regulatory requirements of China
Banking and Insurance Regulatory Commission (the "CBIRC") with
respect to the online insurance business, the Company optimized its
online organization and business system, featuring centralized
operation and unified management, and offered a variety of products
for different scenarios and customers. During the Reporting Period,
the Company's online insurance business grew rapidly, which was
mostly achieved through online-to-offline integration with sales
channels of individual agents, bancassurance and group insurance.
Total premiums under the CBIRC caliber were RMB34,969 million, reaching a record high once
again. In the future, the Company will further strengthen the
online-to-offline integration of its online insurance business,
actively explore on the dedicated online life insurance business,
and provide customers with more convenient online insurance
services.
Integrated Financial Sector
Being customer-centric, the Company fully leveraged the resource
advantages of the fellow members of China Life Insurance (Group)
Company and actively engaged in the construction of a "Life
Insurance plus" integrated financial ecosystem, turning the
integrated financial advantages into a driving force for the
high-quality development of the Company. In 2021, due to the impact
of the comprehensive reform on auto insurance and the slower growth
of this sector, premiums from China Life Property and Casualty
Insurance Company Limited ("CLP&C") cross-sold by the Company
were RMB21,107 million, with the
number of insurance policies increased by 18.0% year on year.
Additional first-year receipts of enterprise annuity funds and
pension security products of China Life Pension Company Limited
cross-sold by the Company were RMB28,197
million. The Company entrusted China Guangfa Bank Co. Ltd.
("CGB") to sell its bancassurance products, with the first-year
regular premiums recording a relatively stable growth. The number
of new debit cards and credit cards jointly issued by the Company
and CGB reached 1,224,000. Meanwhile, in order to satisfy the
diverse needs of its customers, the Company worked with CGB and
CLP&C to carry out various operation activities to provide
customers with a series of quality financial and insurance service
solutions.
By integrating online and offline as well as internal and
external healthcare resources, the Company improved its health
management and service capabilities and actively participated in
the Healthy China program. China Life Inclusive Healthcare Service
Platform continued to diversify its services while upgrading its
system functions. As at the end of the Reporting Period, more than
a hundred types of services were available on the platform, and the
size of the accumulated registered users of the platform led the
industry with an increase of over 35% from the end of 2020. The
Company continued to formulate the China Life aged care system and
deployed towards high-quality resources in the aged care industry
such as rehabilitation, medical care, hospital, health care big
data, and health industrial parks through the China Life Integrated
Aged Care Fund. In 2021, the China Life Integrated Aged Care Fund
reserved a batch of pension and retirement projects that could meet
the diversified and multi-level demands of customers in strategic
regions such as Beijing-Tianjin-Hebei, the Yangtze River Economic Belt, and
the Guangdong-Hong Kong-Macao
Greater Bay Area.
Insurance Products
Adhering to the customer-centric product development concept and
the original role of insurance, the Company fully implemented major
national strategies including Healthy China program, proactively
responding to population aging and rural revitalization,
accelerated insurance product innovation and advanced the
supply-side reform of insurance products to create a diversified
product system.
By closely integrating the Healthy China program with its own
business development, the Company consistently optimized and
upgraded its health insurance products and strengthened the
innovative research and development of illness insurance products
and medical insurance products, etc., in terms of the insured
customer group, scope of cover, and protection functions, so as to
offer diversified health protections. The Company actively served
the national strategy of responding to population aging and
deepened its research in insurance coverage and benefits. By
leveraging the advantages of the long-term risk protection of
insurance products and the long-term application of insurance fund,
the Company launched the exclusive commercial pension insurance and
special annuity insurance products for the elderly customers. It
also developed exclusive insurance products to facilitate rural
revitalization strategy, proactively playing its role in protecting
people's well-being.
In 2021, the Company newly developed and upgraded a total of 160
products, including 12 life insurance products, 138 health
insurance products, two accident insurance products, and eight
annuity insurance products. Out of these products, 144 were
protection-oriented insurance products, and 16 were long-term
savings insurance products.
Investment Business
In 2021, domestic bond yields fluctuated within a tight range,
which rose at first and then fell down, and the interest rate pivot
trended downwards on the whole. The A-share market was volatile,
with significant sector divergence. The Company always adhered to
its strategic consistency, prioritized asset-liability management
in using insurance funds, firmly implementing its medium- to
long-term strategic plan of asset allocation, and making flexible
tactical allocations in response to the market change. Firstly, the
Company seized the opportunity of a relatively high interest rate
in the first half of 2021 and increased allocation to assets with
long durations such as government bonds to further narrow the
duration gap. Secondly, the Company prudently controlled equity
risk exposures in open market to reduce portfolio volatility and
secure the investment gains. Thirdly, the Company strengthened the
innovation in alternative investment models, and positioned for
sectors with prime prospects to establish a diversified investment
portfolio.
As at the end of the Reporting Period, the Company's investment
assets reached RMB4,716,401 million,
an increase of 15.2% from the end of 2020. Among the major types of
investments, the percentage of investment in bonds rose to 48.20%
from 41.97% as at the end of 2020, the percentage of term deposits
changed to 11.23% from 13.32% as at the end of 2020, the percentage
of investment in debt-type financial products changed to 9.41% from
11.08% as at the end of 2020, and the percentage of investment in
stocks and funds (excluding money market funds) changed to 8.75%
from 11.31% as at the end of 2020.
In 2021, the Company's net investment income was RMB188,770 million, rising by 16.0% year on year,
an increase of RMB25,987 million from
2020. Since the Company consistently increased its allocation to
bonds with long durations in recent years, and the income from
investments in associates and joint ventures also increased, the
net investment yield was 4.38% for 2021, up by 4 basis points from
2020. The gross investment income of the Company reached
RMB214,057 million, rising by 7.8%
year on year, an increase of RMB15,461
million from 2020. Gross investment yield was 4.98%, down by
32 basis points from 2020. Affected by the fluctuation in the
equity market, the comprehensive investment yield taking into
account the current net fair value changes of available-for-sale
securities recognized in other comprehensive income was 4.87%, down
by 146 basis points from 2020.
2022 Outlook
For the year 2022, by sticking to the original role of
insurance, we will consistently deepen the supply-side reforms and
improve our capacity of insurance service supply with steady
progress. Besides, we will lead the high-quality development of the
industry with our own high-quality development, aiming to building
a world-class life insurance company and rewarding the shareholders
and people from all walks of life with satisfactory operating
performances.
About China Life Insurance Company Limited
China Life Insurance Company Limited is a life insurance company
established in Beijing, China on
30 June 2003 according to the
"Company Law of the People's Republic of
China" and the "Insurance Law of the People's Republic of China". The Company
was successfully listed on the New York Stock Exchange, the Hong
Kong Stock Exchange and the Shanghai Stock Exchange on 17 and
18 December 2003, and 9 January 2007, respectively. The Company's
registered capital is RMB28,264,705,000.
The Company is a leading life insurance company in China and possesses an extensive distribution
network comprising exclusive agents, direct sales representatives,
and dedicated and non-dedicated agencies. The Company is one of the
largest institutional investors in China, and becomes one of the largest
insurance asset management companies in China through its controlling shareholding in
China Life Asset Management
Company Limited. The Company also has controlling shareholding in
China Life Pension Company
Limited.
Our products and services include individual life insurance,
group life insurance, and accident and health insurance. The
Company is a leading provider of individual and group life
insurance, annuity products and accident and health insurance in
China. As at 31 December 2021, the Company had approximately
323 million long-term individual and group life insurance policies,
annuity contracts, and long-term health insurance policies in
force. We also provide both individual and group accident and
short-term health insurance policies and services.
The 2021 consolidated financial statements of the Company
prepared in accordance with the International Financial Reporting
Standards have been audited by PricewaterhouseCoopers based on the
International Standards on Auditing and PricewaterhouseCoopers has
issued standard unqualified opinions on the 2021 consolidated
financial statements.
Forward-looking statements
Certain statements contained in this press release may be viewed
as "forward-looking statements" as defined by Section 27A of the
U.S. Securities Act of 1933 and Section 21E of the U.S. Securities
Exchange Act of 1934, as amended. Such forward-looking statements
involve known and unknown risks, uncertainties and other factors,
which may mean that the actual performance, financial condition or
results of operations of the Company could be materially different
from any future performance, financial condition or results of
operations implied by such forward-looking statements. Further
information regarding these risks, uncertainties and other factors
is included in the Company's Annual Report on Form 20-F for the
fiscal year ended 31 December 2020
filed with the U.S. Securities and Exchange Commission, or SEC, on
29 April 2021; and in the Company's
other filings with the SEC. You should not place undue reliance on
these forward-looking statements. Unless otherwise stated, all
information provided in this press release is as of the date of
this press release, and the Company undertakes no duty to update
such information, except as required under applicable law.
Unless otherwise indicated, the Chinese insurance market
information set forth in this press release is based on public
information released by China Banking and Insurance Regulatory
Commission.
View original
content:https://www.prnewswire.com/news-releases/china-life-insurance-company-limited-announces-2021-annual-results-h-shares-301510099.html
SOURCE China Life